Ponatinib (Pon) in Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (All).
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Ponatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Expanded access; Therapeutic Use
- Acronyms OPAL observatory
- 21 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association